309 related articles for article (PubMed ID: 14507914)
1. Direct transcriptional regulation of RelB by 1alpha,25-dihydroxyvitamin D3 and its analogs: physiologic and therapeutic implications for dendritic cell function.
Dong X; Craig T; Xing N; Bachman LA; Paya CV; Weih F; McKean DJ; Kumar R; Griffin MD
J Biol Chem; 2003 Dec; 278(49):49378-85. PubMed ID: 14507914
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor-mediated suppression of RelB in antigen presenting cells: a paradigm for ligand-augmented negative transcriptional regulation.
Griffin MD; Dong X; Kumar R
Arch Biochem Biophys; 2007 Apr; 460(2):218-26. PubMed ID: 17367745
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional activity of a fluorinated vitamin D analog on VDR-RXR-mediated gene expression.
Sasaki H; Harada H; Handa Y; Morino H; Suzawa M; Shimpo E; Katsumata T; Masuhiro Y; Matsuda K; Ebihara K
Biochemistry; 1995 Jan; 34(1):370-7. PubMed ID: 7819220
[TBL] [Abstract][Full Text] [Related]
4. Regulation of relB in dendritic cells by means of modulated association of vitamin D receptor and histone deacetylase 3 with the promoter.
Dong X; Lutz W; Schroeder TM; Bachman LA; Westendorf JJ; Kumar R; Griffin MD
Proc Natl Acad Sci U S A; 2005 Nov; 102(44):16007-12. PubMed ID: 16239345
[TBL] [Abstract][Full Text] [Related]
5. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene.
D'Ambrosio D; Cippitelli M; Cocciolo MG; Mazzeo D; Di Lucia P; Lang R; Sinigaglia F; Panina-Bordignon P
J Clin Invest; 1998 Jan; 101(1):252-62. PubMed ID: 9421488
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
[TBL] [Abstract][Full Text] [Related]
8. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
[TBL] [Abstract][Full Text] [Related]
9. 1alpha,25-dihydroxyvitamin D3 and a variety of its natural metabolites transcriptionally repress nuclear-factor-kappaB-mediated interleukin-8 gene expression.
Harant H; Andrew PJ; Reddy GS; Foglar E; Lindley IJ
Eur J Biochem; 1997 Nov; 250(1):63-71. PubMed ID: 9431991
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor.
Alroy I; Towers TL; Freedman LP
Mol Cell Biol; 1995 Oct; 15(10):5789-99. PubMed ID: 7565732
[TBL] [Abstract][Full Text] [Related]
11. 20,23-dihydroxyvitamin D3, novel P450scc product, stimulates differentiation and inhibits proliferation and NF-kappaB activity in human keratinocytes.
Janjetovic Z; Tuckey RC; Nguyen MN; Thorpe EM; Slominski AT
J Cell Physiol; 2010 Apr; 223(1):36-48. PubMed ID: 20020487
[TBL] [Abstract][Full Text] [Related]
12. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element.
Imai Y; Pike JW; Koeffler HP
Leuk Res; 1995 Mar; 19(3):147-58. PubMed ID: 7700077
[TBL] [Abstract][Full Text] [Related]
13. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D-resistant rickets and type 1 diabetes in a child with compound heterozygous mutations of the vitamin D receptor (L263R and R391S): dissociated responses of the CYP-24 and rel-B promoters to 1,25-dihydroxyvitamin D3.
Nguyen M; d'Alesio A; Pascussi JM; Kumar R; Griffin MD; Dong X; Guillozo H; Rizk-Rabin M; Sinding C; Bougnères P; Jehan F; Garabédian M
J Bone Miner Res; 2006 Jun; 21(6):886-94. PubMed ID: 16753019
[TBL] [Abstract][Full Text] [Related]
15. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes.
Ellison TI; Eckert RL; MacDonald PN
J Biol Chem; 2007 Apr; 282(15):10953-62. PubMed ID: 17310066
[TBL] [Abstract][Full Text] [Related]
16. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the human cyclin C gene via multiple vitamin D3-responsive regions in its promoter.
Sinkkonen L; Malinen M; Saavalainen K; Väisänen S; Carlberg C
Nucleic Acids Res; 2005; 33(8):2440-51. PubMed ID: 15863722
[TBL] [Abstract][Full Text] [Related]
18. Identification of 1 alpha,25-dihydroxyvitamin D3 response elements in the human transforming growth factor beta 2 gene.
Wu Y; Craig TA; Lutz WH; Kumar R
Biochemistry; 1999 Mar; 38(9):2654-60. PubMed ID: 10052935
[TBL] [Abstract][Full Text] [Related]
19. Singly dehydroxylated A-ring analogues of 19-nor-1alpha,25-dihydroxyvitamin D3 and 19-nor-22-oxa-1alpha,25-dihydroxyvitamin D3: novel vitamin D3 analogues with potent transcriptional activity but extremely low affinity for vitamin D receptor.
Okano T; Nakagawa K; Tsugawa N; Ozono K; Kubodera N; Osawa A; Terada M; Mikami K
Biol Pharm Bull; 1998 Dec; 21(12):1300-5. PubMed ID: 9881643
[TBL] [Abstract][Full Text] [Related]
20. Nuclear factor of activated T cells (NFAT) as a molecular target for 1alpha,25-dihydroxyvitamin D3-mediated effects.
Takeuchi A; Reddy GS; Kobayashi T; Okano T; Park J; Sharma S
J Immunol; 1998 Jan; 160(1):209-18. PubMed ID: 9551973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]